 | Up a level |
Journal Article
Stilgenbauer, Stephan, Cymbalista, Florence, Leblond, Veronique, Delmer, Alain, Ibach, Stefan, Choquet, Sylvain, Dartigeas, Caroline, Cazin, Bruno, Tournilhac, Olivier, Pegourie, Brigitte, Seiler, Till M., Soekler, Martin, Zirlik, Katja, Alt, Juergen, Huber, Henriette, Bloehdorn, Johannes, Tausch, Eugen, Zenz, Thorsten, Hallek, Michael, Schetelig, Johannes, Dreger, Peter and Doehner, Hartmut (2014). Alemtuzumab Combined with Dexamethasone, Followed By Alemtuzumab Maintenance or Allo-SCT in ultra High-risk CLL: Final Results from the CLL2O Phase II Study. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Stilgenbauer, Stephan, Cymbalista, Florence, Leblond, Veronique, Delmer, Alain, Mack, Silja, Buehler, Andreas, Winkler, Dirk, Zenz, Thorsten, Busch, Raymonde, Ibach, Stefan, Choquet, Sylvain, Caroline, Dartigeas, Cazin, Bruno, Tournilhac, Olivier, Seiler, Till M., Zirlik, Katja, Alt, Juergen, Soekler, Martin, Schetelig, Johannes, Dreger, Peter, Hallek, Michael and Doehner, Hartmut (2012). Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971